2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on High-risk Resectable Stage III Melanoma: Can 2 Cycles of Neoadjuvant Ipi + Nivo Induce High pCR and Omit TLND to Reduce Surgical Morbidity?

0 views
July 22, 2020
Comments 0
Login to view comments. Click here to Login